Measles cases are surging in Europe and the US. This is what the anti-vax conspiracy theory has brought us
So Wakefield's infamous Lancet study, in which he claimed a link between the MMR (measles, mumps and rubella) vaccine and autism, going as far as to pin down the exact mechanism by which one led to the other, was new only in so far as it had all the branding of reputable research, when in fact it was maleficent woo-woo, a phenomenon as old as knowledge. It was noticeable, though, that it fell on parched ground – a lot of people were very keen for it to be true. That was partly simple news appetite: vaccines are inherently boring. Devised by humans co-operating with one another, motivated by nothing more complicated than a desire to help the species – and indiscriminately, no one baby more worthy of protection than any other – there is no animating conflict here, nothing hidden, no complexity. Is there anything more tedious than humanity at its finest? So wouldn't it be at least piquant if it turned out to be a giant mistake?
Alongside that, there was a perception that autism diagnoses had gone through the roof, and that wasn't wrong. The increase in recorded incidence was 787% between 1998 and 2018, and no amount of, 'Steady on, guys – it might just be because we've got better at understanding what we're looking at' would deter people from wishing for one simple answer. Wakefield also landed his bogus study just as performative parenting was getting under way – a new understanding of child-rearing, in which parenting well became the summit of moral excellence, and the way to prove your credentials was to be excessively cautious about absolutely everything. It seemed pretty Calvinist – the fundamentals of parenting superiority were mysterious, but you could spot the Chosen Parent by the fact that they never ran with the herd.
The depressing thing about the anti-vax timeline is that the collective global mind worked as it should and yet didn't work at all. Other scientists tried to replicate Wakefield's results, and couldn't. The right questions were asked and he was discredited. The lie might have gone around the world, but when the truth finally did get its pants on, it won a decisive victory. Yet a generalised distrust of vaccination as a concept had been spawned, ready to meet any fresh infectious disease. That didn't delay the Covid vaccine rollout – it's hard to see how it could have been faster – but did sully the triumph with the loud disquiet of a minority who thought they were being deliberately poisoned by the state.
The effects of the MMR controversy, specifically, are revealing themselves now, nearly 30 years later: measles cases in Europe are at the highest levels in 25 years; in the US, cases are at a 33-year-high; last week a child in Liverpool died having contracted measles. It's unknown whether the child was vaccinated (no vaccine can guarantee complete immunity) and it doesn't matter – it wouldn't make it any less tragic if that child's parents had been caught in the swirl of misinformation, or any more tragic if they hadn't. And it wouldn't be germane anyway: everybody is better protected when everybody is vaccinated. This is never a decision you are making just for yourself.
It's probably the most depressing conspiracy theory there is, not because the impacts are so much graver than some cranks who believe the Earth to be flat, but because vaccination is the most concrete proof of how much we rely on one another's care and rationality. That's true beyond disease – we also need each other for democracy, science, culture, civic life and everything – but in no other area can you see that, count it and put it on a graph.
Zoe Williams is a Guardian columnist
Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
28 minutes ago
- Daily Mail
New study shows using marijuana triples risk of developing cancer
People who frequently use marijuana more than triple their risk of developing oral cancer , a new study found. About half of US adults say they have ever tried marijuana, with about 17.7million suffering from symptoms of cannabis use disorder (CUD) . The condition requires a formal diagnosis after fulfilling several criteria, such as using the drug despite the negative impacts it has on a person's life and relationships. University of California , San Diego researchers followed 45,000 people, some with cannabis use disorder, for five years. They discovered that daily smokers were 3.25 times more likely to develop oral cancer than those without the disorder. Dr Raphael Cuomo, an anesthesiology professor at UC San Diego School of Medicine who led the analysis, said: 'Cannabis smoke contains many of the same carcinogenic compounds found in tobacco smoke, which have known damaging effects on the epithelial tissue that lines the mouth.' Cannabis smoke packs a heavy load of toxic chemicals and carcinogens, about 2,600 of them, similar to tobacco smoke. But researchers are only recently getting a fuller understanding of what those chemicals are. They now know that marijuana smoke contains hundreds of polycyclic aromatic hydrocarbons (PAHs), benzene, and ammonia. These chemicals adhere to mucus membranes in the mouth, enabling carcinogens to seep into oral tissue. Meanwhile, THC, the psychoactive chemical in marijuana, can suppress crucial immune system pathways that would typically patrol for, and kill, those rogue cells. Of the more than 45,000 patients included in the study, 949 had cannabis use disorder. The group that did not smoke or smoked only occasionally remained either weed free or only occasional users over the five-year study. Over 97 percent were still abstinent or infrequent users by the time researchers followed up. During the study, 106 patients were diagnosed with oral cancer. Among people without CUD, the rate of oral cancer was 0.23 percent, which matches general population rates. However, among participants with CUD, 0.74 percent developed oral cancer. Oral cancer includes cancerous growths that develop in the mouth and throat, including the lips, tongue, gums, the floor of the mouth and the roof of the mouth. About one in 59 men and 1 in 139 women will develop oral cancer at some point in their lives. Oral cancers account for about three percent of cancers diagnosed in the US every year, with about 58,500 diagnoses and 12,250 deaths annually. Researchers said their findings will have implications for cancer screening practices in primary care and mental health settings, as patients with CUD often present with overlapping social and behavioral risk factors, including tobacco use, alcohol use, and a lower likelihood of engaging in preventive healthcare. People with CUD who were also tobacco users were 6.24 times more likely to get oral cancer. Age also played a role, with each additional year of age increasing cancer risk by about four times per year. Like tobacco smokers, marijuana smokers see damage to their lung and throat cells, leading to abnormal cell growth that can cause cancer and tissue changes. Those effects can occur in people who are not tobacco smokers, though, indicating that marijuana smoke can be just as harmful on its own as cigarette smoke. Dr Cuomo said: 'These findings add to a growing body of evidence suggesting that chronic or problematic cannabis use may contribute to cancer risk in tissues exposed to combustion products.' Their findings were published in the journal Preventive Medicine Reports . In the United States, marijuana is fully legal for recreational and medicinal use in 29 states. It is entirely illegal in four states. The majority of the public, about 88 percent , supports legalization, according to the Pew Research Center. But public health experts are raising concerns over potential long-term effects, of which scientists still do not have a complete understanding. In June, University of California researchers reviewed 24 studies involving 200million people to investigate the relationship between weed and cardiovascular disease, stroke and acute coronary syndrome (ACS) - a group of heart conditions in which there is reduced or blocked blood flow to the heart, such as a heart attack. They found there was a 29 percent higher risk of ACS among cannabis users, a 20 percent higher risk for stroke and double the risk of dying from cardiovascular disease, which includes coronary artery disease, heart failure and irregular heartbeats. Last month, findings from an FDA-run clinical trial were released, investigating dangerous liver enzyme spikes in people who consumed cannabis. The results showed that eight users of CBD, the substance derived from the hemp plant that's free of the psychoactive chemical THC, developed enzyme spikes above the safe threshold, raising the risk of chronic liver damage or failure. Seven people dropped out due to liver concerns between weeks three and four. However, everyone's liver tests normalized after quitting CBD. Meanwhile, regular use of potent cannabis in adolescence has been linked to long-term changes in brain structure, particularly in the prefrontal cortex, the region responsible for decision-making, emotional regulation, and impulse control. This is also the age when many psychotic disorders first appear. THC may trigger schizophrenia or psychotic episodes in individuals with genetic predispositions. A 2022 review by University of Bath researchers, which analyzed 20 studies involving 120,000 people, found users of high-potency cannabis were four times more likely to develop addiction and three to five times more likely to suffer a psychotic break compared to those using lower-potency strains. Earlier this year, a report in JAMA Network Open found that emergency room visits in Ontario, Canada, linked to schizophrenia in marijuana users tripled after legalization. Between 2006 and 2022, the rate of schizophrenia among those with cannabis use disorder climbed from four percent to over 10 percent. In contrast, just 0.6 percent of non-users developed the condition.
Daily Mail
an hour ago
- Daily Mail
Dirty habit followed by 18million Americans TRIPLES the risk of getting cancer
People who frequently use marijuana more than triple their risk of developing oral cancer, a new study found. About half of US adults say they have ever tried marijuana, with about 17.7million suffering from symptoms of cannabis use disorder (CUD). The condition requires a formal diagnosis after fulfilling several criteria, such as using the drug despite the negative impacts it has on a person's life and relationships. University of California, San Diego researchers followed 45,000 people, some with cannabis use disorder, for five years. They discovered that daily smokers were 3.25 times more likely to develop oral cancer than those without the disorder. Dr Raphael Cuomo, an anesthesiology professor at UC San Diego School of Medicine who led the analysis, said: 'Cannabis smoke contains many of the same carcinogenic compounds found in tobacco smoke, which have known damaging effects on the epithelial tissue that lines the mouth.' Cannabis smoke packs a heavy load of toxic chemicals and carcinogens, about 2,600 of them, similar to tobacco smoke. But researchers are only recently getting a fuller understanding of what those chemicals are. They now know that marijuana smoke contains hundreds of polycyclic aromatic hydrocarbons (PAHs), benzene, and ammonia. These chemicals adhere to mucus membranes in the mouth, enabling carcinogens to seep into oral tissue. Meanwhile, THC, the psychoactive chemical in marijuana, can suppress crucial immune system pathways that would typically patrol for, and kill, those rogue cells. Of the more than 45,000 patients included in the study, 949 had cannabis use disorder. The group that did not smoke or smoked only occasionally remained either weed free or only occasional users over the five-year study. Over 97 percent were still abstinent or infrequent users by the time researchers followed up. During the study, 106 patients were diagnosed with oral cancer. Among people without CUD, the rate of oral cancer was 0.23 percent, which matches general population rates. However, among participants with CUD, 0.74 percent developed oral cancer. Oral cancer includes cancerous growths that develop in the mouth and throat, including the lips, tongue, gums, the floor of the mouth and the roof of the mouth. About one in 59 men and 1 in 139 women will develop oral cancer at some point in their lives. Oral cancers account for about three percent of cancers diagnosed in the US every year, with about 58,500 diagnoses and 12,250 deaths annually. Researchers said their findings will have implications for cancer screening practices in primary care and mental health settings, as patients with CUD often present with overlapping social and behavioral risk factors, including tobacco use, alcohol use, and a lower likelihood of engaging in preventive healthcare. People with CUD who were also tobacco users were 6.24 times more likely to get oral cancer. Age also played a role, with each additional year of age increasing cancer risk by about four times per year. Like tobacco smokers, marijuana smokers see damage to their lung and throat cells, leading to abnormal cell growth that can cause cancer and tissue changes. Those effects can occur in people who are not tobacco smokers, though, indicating that marijuana smoke can be just as harmful on its own as cigarette smoke. Dr Cuomo said: 'These findings add to a growing body of evidence suggesting that chronic or problematic cannabis use may contribute to cancer risk in tissues exposed to combustion products.' Their findings were published in the journal Preventive Medicine Reports. In the United States, marijuana is fully legal for recreational and medicinal use in 29 states. It is entirely illegal in four states. The majority of the public, about 88 percent, supports legalization, according to the Pew Research Center. But public health experts are raising concerns over potential long-term effects, of which scientists still do not have a complete understanding. In June, University of California researchers reviewed 24 studies involving 200million people to investigate the relationship between weed and cardiovascular disease, stroke and acute coronary syndrome (ACS) - a group of heart conditions in which there is reduced or blocked blood flow to the heart, such as a heart attack. They found there was a 29 percent higher risk of ACS among cannabis users, a 20 percent higher risk for stroke and double the risk of dying from cardiovascular disease, which includes coronary artery disease, heart failure and irregular heartbeats. Last month, findings from an FDA-run clinical trial were released, investigating dangerous liver enzyme spikes in people who consumed cannabis. The results showed that eight users of CBD, the substance derived from the hemp plant that's free of the psychoactive chemical THC, developed enzyme spikes above the safe threshold, raising the risk of chronic liver damage or failure. Seven people dropped out due to liver concerns between weeks three and four. However, everyone's liver tests normalized after quitting CBD. Meanwhile, regular use of potent cannabis in adolescence has been linked to long-term changes in brain structure, particularly in the prefrontal cortex, the region responsible for decision-making, emotional regulation, and impulse control. This is also the age when many psychotic disorders first appear. THC may trigger schizophrenia or psychotic episodes in individuals with genetic predispositions. A 2022 review by University of Bath researchers, which analyzed 20 studies involving 120,000 people, found users of high-potency cannabis were four times more likely to develop addiction and three to five times more likely to suffer a psychotic break compared to those using lower-potency strains. Earlier this year, a report in JAMA Network Open found that emergency room visits in Ontario, Canada, linked to schizophrenia in marijuana users tripled after legalization. Between 2006 and 2022, the rate of schizophrenia among those with cannabis use disorder climbed from four percent to over 10 percent. In contrast, just 0.6 percent of non-users developed the condition.
The Sun
an hour ago
- The Sun
Five sneaky tricks supermarkets and brands use to get YOU to spend more as fat jabs hit sales
WAISTLINES are not the only things shrinking with the use of weight-loss jabs – supermarket bottom lines are too. Food sales are falling, and data-analyst Kantar blames hunger-repressing injections like Mounjaro for a 0.4 per cent drop in the four weeks to June 24. 8 A 4 per cent rise in food prices in the past year is also reducing spending. Now the big stores and brands are fighting back. Rosie Taylor reveals the sneaky ways they try to make us part with our cash. TEMPTING YOUR TASTEBUDS BRANDS are launching new flavour combinations for staple products they think will be a big hit with shoppers. Heinz has released a Sweet Sriracha tomato ketchup (£2.68 at Asda), and Bird's Eye has launched fish fillets coated in a Mexican tortilla crumb (£1.98 from Asda). Brands are also releasing new products with trimmer waistlines in mind. These include Tango Sugar Free Strawberry Smash (eight cans cost £3.34 at Asda) and Pepsi's zero sugar Cream Soda flavour (eight cans costs £3.75 from Waitrose). Dr Jenna Vyas-Lee from Kove Minds clinic in Southwark, London, says: 'We get a hit of dopamine — the feel-good hormone — from trying new things. 'So, a new flavour of Coke speaks to that curious part of our brain. Feeding your curiosity by buying that item makes you feel good.' TIP: Tempted by an intriguing new flavour? Take a picture of it and add it to your shopping list for next week. Take time to think about whether you really want it, or if it's just an impulse buy. Nutritionist reveals which stars could be suffering from 'Ozempic face' & why some like Kelly Clarkson get away without 8 8 SELLING FAT JABS SUPERMARKETS are finding new ways to cash in on the weight-loss trend. Asda and Morrisons are both selling fat jabs through online clinics. Asda is selling Wegovy injection doses from £118.98, while Morrisons is selling Mounjaro self-injectable pens from £129 a month. An investigation by Which? found buying from a registered pharmacy, like Asda, was safer than buying from unregulated online clinics where some fake versions of the drugs have been found for sale. TIP: Always speak to your GP before starting any new medication and only ever buy from registered pharmacies. 8 LAUNCHING FITNESS RANGES ASDA launched a new sportswear brand, Gym Locker, in January, to target fitness-conscious shoppers. Women's wear such as a sports bra and shorts start at £14. Men's wear starts at £12. While Aldi launched a budget Specialbuy fitness range in May, including a reformer pilates machine for £149.99, an £11.99 smart watch to track your steps and heart rate, and yoga mats for £5.99. Lidl launched a high protein product range on TikTok shop in February. The £5 bundles on offer included 500g packs of protein powder and protein pancake mixes. CREATING SPECIAL OCCASIONS SUPERMARKETS launch huge product promotions for Christmas, Valentine's Day and Easter. Now, they're finding new ways to encourage us to buy all year round. Asda is advertising a Summer Vibes promotion for picnics, barbecues and 'summer breakfast' products. Top picks include Birds Eye 12 Chicken Dippers for £2.48. But not on the list is its own-brand Just Essentials 20 breaded chicken nuggets at £1.10, a saving of £1.38. Tesco is pushing a Summer Essentials range, including a bistro set of two chairs and a table for £112.99 (pictured). The same set is available at Robert Dyas for £87.99, a saving of £25. Presenting products as a theme encourages us to buy more, said Patrick Young from research consultancy PRS In Vivo: 'It makes shoppers want to buy all the things they need to create that sense of occasion.' TIP: Always go shopping armed with a list so you are less likely to be swayed by marketing. PLAYING LAYOUT MIND GAMES WE'RE all guilty from time to time of walking away with goodies that weren't on our shopping list. But did you know supermarkets are constantly trying to get us to overspend using secret tactics? Shops invest heavily in 'space planning', where the store layouts are designed to get customers spending more. Techniques to catch our eye include putting stickers on the floor or signs around the shelves to highlight a new product or special offers. Brands in particular are jostling to get store customers' eyeballs on their goods — research shows shoppers ignore 80 per cent of products within two seconds of looking. Brands will therefore do deals with supermarkets to position their items in the best places along aisles. 'There is a lot of competition between brands on the supermarket shelf, it's an arms race,' said Young, adding: 'People tend to look in the middle and slightly down, so products at the top of the shelves could be better value.' Another super-sneaky tactic brands are using is to super-size packaging so products stand out more on shelves. TIP: Look at the top and bottom shelves to check for cheaper options. Always compare the price per gram on the label, instead of just looking at the item's price. This is the best way of seeing which products offer the best value for money. RUNNING FOMO DEALS ANOTHER effective tactic stores use is putting time-limits on deals, for example Morrisons' When It's Gone It's Gone deals. 'This creates a sense of scarcity [the fear something could run out] and people also don't want to miss a chance to get value for money,' said Young. Shoppers may feel like they need to rush into buying deals, even when they are not actually great value. Nearly nine out of ten UK adults spend on non-essential little luxuries every month, including takeaway coffees or buying a drink or meal for a friend, according to research by Chase Bank. TIP: 'A good deal is only a good deal if you need it,' said Dr Vyas-Lee. If the product is something you buy regularly, such as toilet roll, it makes sense to pick up a two-for-one deal. But if it is a one-off purchase, you could be wasting your money. Gas boost for needy BRITISH GAS ENERGY TRUST has reopened its Individuals and Families Fund. It offers up to £1,700 to those struggling with energy debt, regardless of their supplier. Last year it helped 1,800 households, writing off £839,000 in debt. Boss Jessica Taplin said: 'This fund will help those who need it most get on stable ground and keep their homes and families warm and safe.' Grit-ish airways BRITISH AIRWAYS has reported a bumper 48 per cent rise in operating profits to £824million for the first half of the year. It comes despite a £40million hit from Heathrow's temporary closure in March due to a substation fire. 8 The buoyant airline ramped up its flight programme, increasing capacity by 2.1 per cent and boosting revenues. Parent company International Airlines Group (IAG), which also owns Aer Lingus, Iberia, and Vueling, saw earnings jump 43.5 per cent to £1.88billion, with pre-tax profits climbing to £1.75billion. Meanwhile, the debate over Heathrow's third runway intensified yesterday as IAG backed rival proposals from hotel tycoon Surinder Arora and Heathrow's owners, calling both 'credible.' However, IAG boss Luis Gallego said: 'We only want to build something affordable that'll allow everybody to have more passengers, but they don't have to pay the level they are paying today.' Arora's £25billion plan for a shorter, 2,800-metre runway aims to avoid costly diversions of the M25 but does not include redevelopment of the central terminal area. Heathrow favours a full-length, 3,500-metre runway to maximise operational flexibility. It would cost £21billion, with its full expansion plan — including terminals and infrastructure — estimated at £49billion. Transport Secretary Heidi Alexander will assess the competing plans this summer. Homes rise HOUSE prices rose by 0.6 per cent in July, reversing a 0.9 per cent drop in June, according to Nationwide. Annual growth climbed to 2.4 per cent, with the average home now priced at £272,664. With the Bank of England expected to cut interest rates next week, the housing market could see a fresh boost in activity in the months ahead. Mark Harris, boss of mortgage broker SPF Private Clients, said: 'We could be in for a busy autumn. Lenders continue to trim mortgage rates.' Fall slows THE downturn in UK factory production eased slightly again last month as the sector posted its strongest performance for half a year. The S&P GLOBAL UK manufacturing PMI rose to 48.0 from 47.7, signalling a slower decline — but it was still below the growth threshold of 50. Manufacturers blamed weak domestic and export demand, higher labour costs, and geopolitical pressures. Meanwhile, rising staff costs resulted in July being the ninth consecutive month of falling employment. Phone scams do a number on you By Lucy Andrews BEING targeted by a scammer can be a worrying experience. But has a fraudster ever pretended to be YOU to trick people out of their cash? That's exactly what happened to me, when I discovered my phone number had been 'spoofed'. It's a horrible form of identity fraud and a cunning way for con artists to attempt to steal money from unsuspecting victims, as the number appears to be from a trusted source. It all began six months ago, when I started getting mysterious phone calls from strangers claiming they had received missed calls from me. But when I checked my call log each time, I could see that I never phoned them. I would tell the caller that they made a mistake, and hang up. I was suspicious that these were scammers trying to lure me into handing over money in some way, so I made sure to block the numbers after I ended the phone calls. That was until last week, when I received a WhatsApp from a lady I didn't know. 'Hello, did you call me?' the text read. She sent a screenshot of her call log – and surprisingly, my phone number was at the top of the list. I asked my phone company, ID Mobile, what had happened. It said my phone number appears to have been spoofed. I paid £25 to change my number, as it made me feel sick thinking scammers were pretending to be me. Spoofing is becoming a big problem. The telecoms regulator, Ofcom, is so concerned about the growing threat that it launched a consultation last year on how to address the issue. It said a call from a spoofed number could appear more trustworthy, and 'victims are more likely to share personal information'. Worryingly, phone companies can't do a lot about spoofing, but you can take steps to prevent it happening. Be wary of who you share your number with. Most website forms will ask for it, but you don't always need to give your number away.
